Best Cancer Hospital in India, Cancer Hospital in Delhi, Cancer Research Institute India. Finding a Top Thyroid Surgeon, Finding a Qualified Surgeon for Thyroidectomy, Endocrine Surgeon, Endocrine Surgery. Thyroid surgery is not very common, so it is important that you find a surgeon who is experienced in the procedure if you need one.
More experienced surgeons typically have lower rates of complications after thyroid surgery. To find an experienced thyroid surgeon, consider traveling to a university hospital or medical center that handles numerous thyroid surgeries. Before you select a thyroid surgeon, find out how many surgeries he or she performs each year.
You want a surgeon who is doing at least 50 or more thyroid and parathyroid surgeries each year. Gene May Boost Death Risk From Most Common Thyroid Cancer. FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.
The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, which accounts for 85 percent to 90 percent of all thyroid cancers. After an average follow-up period of 33 months, 5 percent of those with the BRAF V600E mutation had died, compared with 1 percent of those without the mutation, according to the study in the April 10 issue of the Journal of the American Medical Association. However, the link between this mutation and increased risk of death was not independent of tumor characteristics, the study authors noted in a journal news release.
This, and the fact that the overall death rate from papillary thyroid cancer is low, means that it is unclear how to use these findings to reduce death risk in patients with this type of cancer, said Dr. TATA Memorial Hospial. Mumbai - India. TATA Memorial Hospial. Mumbai - India. ATA PATIENT EDUCATION. American Thyroid Association. Dr. Guttler's Santa Monica Thyroid Diagnostic Center - thyroid cancer, thyroid problems, hyperthyroid, hypothyroid, thyroid doctor, thyroidologist, Hypothyroid/Hashimoto's, Goiter. Thyroidologists.com. Recurrence of thyroid cancer 'could be predicted' with microRNAs.
'Gene signature' test diagnoses benign thyroid growths. A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile.
The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. "We have developed a 'gene signature' that effectively identifies benign thyroid nodules," said Hernan Gonzalez, MD, PhD, associate professor at the Pontifical Catholic University of Chile in Santiago. "This test is potentially useful to identify patients who do not require surgery. " The thyroid gland, located in the front of the neck, secretes thyroid hormone.
This hormone is involved in many bodily processes, including turning food into energy. What You Need To Know About™ Thyroid Cancer. This National Cancer Institute (NCI) booklet is for you— someone who has just been diagnosed with cancer of the thyroid. In 2013, about 45,000 women and 15,000 men will be diagnosed with thyroid cancer in the United States. Most will be older than 45. Learning about medical care for thyroid cancer can help you take an active part in making choices about your care. This booklet tells about… Diagnosis and stagingTreatmentFollow-up careTaking part in research studies You can read this booklet from front to back.
This booklet has lists of questions that you may want to ask your doctor. Two new weapons against thyroid cancer. For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options.
But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels. Two recent clinical trials led by a researcher from the Perelman School of Medicine at the University of Pennsylvania showcase the great promise of these new approaches. The work was presented at the European Cancer Congress (ECCO 17 -- ESMO 38 -- ESTRO 32) in Amsterdam. The first study provides additional data from the phase III DECISION trial of the drug sorafenib, a kinase inhibitor already approved for treatment of kidney and liver cancer, which was presented as a plenary during the 2013 annual American Society of Clinical Oncology meeting.
Measuring segments of genetic material may help predict, monitor recurrence of thyroid cancer. A new analysis has found that the presence of short segments of genetic material (known as microRNA) within papillary thyroid cancer tumors suggests a likelihood of recurrence after patients undergo surgery.
The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that elevated blood levels of the genetic material after surgery may indicate a higher possibility of recurrence after thyroidectomy. FDA approves Nexavar to treat type of thyroid cancer. For Immediate Release: Nov. 22, 2013Media Inquiries: Tara Goodin, 240-402-3157, tara.goodin@fda.hhs.govConsumer Inquiries: 888-INFO-FDA FDA approves Nexavar to treat type of thyroid cancer The U.S.
Food and Drug Administration today expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer. Hypothyroidism and TSH Test. Most doctors rely on the TSH test for diagnosing hypothyroidism.
It's a simple blood test that checks the level of thyroid-stimulating hormone (TSH) in the blood. People with normal thyroid function typically have a TSH level that falls between 0.4 and 4.0 mIU/L. If you are diagnosed with hypothyroidism, the American Association of Clinical Endocrinologists recommends patients keep their TSH level between 0.3 and 3.0 mIU/L. Your doctor will determine the range that is right for you. Understanding Graves' Disease. Why do I need to register or sign in for WebMD to save?
We will provide you with a dropdown of all your saved articles when you are registered and signed in. How Do I Find Out If I Have Graves' Disease? Although Graves' disease can be diagnosed from the results of one or two tests, your doctor may use several methods to double-check the findings and rule out other disorders. An analysis of your blood will show if the levels of two hormones -- tetraiodothyrinine (free T-4) and triiodothyronine (free T-3), which are produced or regulated by the thyroid -- are higher than normal.
Promise for treating papillary thyroid cancer. Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer (PTC).
An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations. R. Dadu and colleagues from M.